Shahjalal Islami Bank MD links banking stress to rapid expansion and weak governance

Dhaka, June 21 -- Shahjalal Islami Bank Managing Director Mosleh Uddin Ahmed has said Bangladesh's banking sector faces deeper challenges now than at any point in recent years, urging stronger regulat... Read More

Minority Caucus Appoints Afam Ogene as Spokesperson

Nigeria, June 21 -- The Minority Caucus of the House of Representatives has appointed Afam Ogene, the lawmaker representing Ogbaru Federal Constituency of Anambra State, as its new spokesperson. The ... Read More

Diabetes remains one of Malaysia's biggest public health challenges, says Sarawak Health director

KUCHING, June 21 -- Non-communicable diseases (NCDs), particularly diabetes, continue to pose major public health challenges in Malaysia. Sarawak State Health Department director Dr Veronica Lugah sa... Read More

Manipur: Rs 1.36 crore released to 6,806 farmers under PM-KISAN's 23rd installment

Guwahati, June 21 -- Reported by Bit Irom Imphal: Following the nationwide release of the 23rd installment of the Pradhan Mantri Kisan Samman Nidhi (PM-KISAN) scheme on June 20, the Manipur governmen... Read More

Nagaland's Hidden Crisis: Sexual Crimes, Patriarchy and Culture of Silence

Written by, June 21 -- Monalisa Changkija While Nagaland has been declared the safest state for women in India, the ground reality begs to differ. Like any other society steeped in toxic muscularity ... Read More

JD Vance names "most important people" in his life - One Indian, one Pakistani

India, June 21 -- US Vice President JD Vance has humorously revealed the names of an Indian and a Pakistani whom he considers among the most important people in his life, identifying one as Pakistani ... Read More

Singapore Clinical Trial: A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating the safety and tolerability of ARD001 in healthy adult subjects and a Phase 2 open-label, multiple-dose study in adult subjects with hemophilia A

Singapore, June 21 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating ... Read More

Singapore Clinical Trial: A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Placebo-Controlled Phase 3 Followed by an Open-Label Extension to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of Radiprodil in Participants With GRIN-Related Neurodevelopmental Disorder

Singapore, June 21 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Pla... Read More

Singapore Clinical Trial: A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solution for Injection (TLX101-Tx) Plus Lomustine Versus Lomustine Alone in Patients with Radiographically Confirmed Recurrent Glioblastoma at First Recurrence (IPAX-3)

Singapore, June 21 -- The Health Sciences Authority received information related to the study titled 'A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solut... Read More

Singapore Clinical Trial: RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib Monotherapy or Daraxonrasib Plus Gemcitabine and Nab-paclitaxel versus Gemcitabine and Nab-paclitaxel as a First-Line Treatment for Patients with Metastatic Pancreatic Adenocarcinoma

Singapore, June 21 -- The Health Sciences Authority received information related to the study titled 'RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib M... Read More

• ««
• «
• 19798
• 19799
• 19800
• 19801
• 19802
• 19803
• 19804
• 19805
• 19806
• 19807
• »
• »»